Concepedia

Shuaiji Lu

SL

Statistics

Publications

2

Citations

73

H-Index

2

Active since

2024

Affiliations

Hubei Cancer Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Third Affiliated Hospital of Harbin Medical University

Shanghai Chest Hospital

Zhejiang Cancer Hospital

Shuaiji Lu is an author at Hubei Cancer Hospital specializing in non-small cell lung cancer treatment, non-small cell lung cancer immunotherapy, and targeted therapy.

Publications per year

2024–2024

2

Publications

2

Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: final analysis of the randomized, phase III RATIONALE-307 trial

Jie Wang, Shuaiji Lu, Xiaohua Yu et al. · ESMO Open · 2024 · 40 citations · Full text

, , +12

Tislelizumab plus chemotherapy as first-line treatment of locally advanced or metastatic nonsquamous non-small-cell lung cancer (final analysis of RATIONALE-304: a randomized phase III trial)

Shuaiji Lu, Jiarui Wang, Yan Yu et al. · ESMO Open · 2024 · 33 citations · Full text

, , +12

1–2 of 2